** Shares of oncology and immunology focused biological products developer Akeso Inc falls 5.7% to HK$47.80; on course for biggest one-day pct decline since March 5
** Stock hits lowest level since March 13
** Co plans sales of 24.8 mln new shares, or 2.86% of the enlarged share capital, to third party investors raising HK$1.18 bln ($153.4 mln) to fund various preclinical programs and for commercialization of products
** Says shares will be sold at HK$47.65 apiece, representing 6.02% discount to Wednesday's close
** Hong Kong's healthcare index slips 0.03%, while Hang Seng Composite Index gains 2% and Hang Seng Index
rises 2.3%
** Stock up 3.1% YTD
($1 = 7.8204 Hong Kong dollars)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
Comments